HIPK2 and neoplasm: HIPK2 can phosphorylate β-catenin for proteasomal degradation [38] and such degradation leads to the transcriptional impairment of several β-catenin target genes, including the vascular endothelial growth factor (VEGF) involved in tumor angiogenesis and tumor growth [39].